Delivery Order SPE2DB22D3501-SPE2DB24FUQ05
- Not listed
- This federal contract award is for the delivery of ADVAIR HFA 230-21 MCG INHALER 12GM to the Defense Logistics Agency (DLA). The $3,619.50 firm fixed price contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies in the world. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025....
- This federal contract award is for the delivery of ADVAIR HFA 45-21 MCG INHALER 12GM to the Defense Logistics Agency (DLA) by prime contractor Amerisourcebergen Drug Corp. The $1,452.33 firm fixed price delivery order has a completion date of March 1, 2024. Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a for-profit organization that serves as a prime contractor providing pharmaceuticals and medical supplies to U.S. government agencies, particularly the Department...
- This federal contract award is for the delivery of ADVAIR HFA 115-21 MCG INHALER 12GM to the Defense Logistics Agency (DLA), a defense agency. The $1,784.22 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The contract has an ultimate completion date of June 17, 2025 and is not a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,255.80 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of ADVAIR HFA 45-21 MCG INHALER 12GM. This contract has a performance period through March 5, 2024 and is not set aside for any specific business category. Amerisourcebergen Drug Corp is the prime contractor on this award, which is part of a larger $999,999,999.00 indefinite delivery contract (IDC)...
- The federal contract award is for the delivery of ADVAIR HFA 115-21 MCG INHALER 12GM, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $3,144.60, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This is a delivery order contract with a firm fixed price, and the ultimate completion date is set for April 22, 2024. The contract does not have a set-aside designation, indicating open...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, provides for the delivery of ADVAIR HFA 230-21 MCG INHALER 12GM to the Defense Logistics Agency (DLA). The $2,360.55 firm fixed price delivery order contract has a completion date of February 26, 2024. Amerisourcebergen Drug Corp, as the prime contractor, will supply this pharmaceutical product from its Corporate Office location in Conshohocken,...
- This federal contract award is for the delivery of ADVAIR HFA 230-21 MCG INHALER 12GM, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $11,405.66, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is a firm fixed price delivery order, with a performance period through March 14, 2024. No set-aside designation was used for this award....
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $1,359.56 firm fixed price delivery order is for the supply of the pharmaceutical product ADVAIR HFA 230-21 MCG INHALER 12GM. The award has a period of performance through March 13, 2024. Amerisourcebergen Drug Corp is a prime contractor that holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through...
- This federal contract award is for the delivery of ADVAIR HFA 115-21 MCG INHALER 12GM, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,872.19 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on July 29, 2024, with a completion date of July 30, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical valued at $999,999,999,...
- The federal contract award is for the delivery of ADVAIR HFA 115-21 MCG INHALER 12GM pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The $5,614.33 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on September 13, 2024, with a completion date of September 16, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical,...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB24FUQ05Delivery Order
This federal contract award is for the delivery of ADVAIR HFA 45-21 MCG INHALER 12GM to the Defense Logistics Agency (DLA). The $5,894.89 firm fixed price contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. As the prime contractor, Amerisourcebergen Drug Corp will deliver the pharmaceutical product from its facility in Conshohocken, Pennsylvania. This award is not associated with any set-aside program. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) valued up to $999,999,999.00 with DLA through December 2025, which serves as the primary vehicle for the company to provide a range of medications and medical supplies to support Department of Defense military treatment programs and facilities worldwide.